mlpd2 ohga2
Name
oaia2
Label
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))
Description

Participant taking ORAL ANTI-INFLAMMATORY ASTHMA DRUGS (LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
asthma inflammation medication_form_shhs respiratory
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,581 -
Yes - - 39 -
Unknown - - 460 -
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,646 1,935 3,581
Yes 15 24 39
Unknown 200 260 460
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,131 237 213 3,581
Yes 31 5 3 39
Unknown 425 14 21 460